The QualityStocks Daily Friday, October 29th, 2021

Today's Top 3 Investment Newsletters

QualityStocks(BSPK) $0.0343 +158.28%

MarketClub Analysis(ATEN) $18.6900 +34.95%

CryptoCurrencyWire(AABB) $0.1470 +27.83%

The QualityStocks Daily Stock List

The Marketing Alliance, Inc. (MAAL)

QualityStocks, MarketBeat, Zacks, Wall Street Resources, The Online Investor and Daily Trade Alert reported earlier on The Marketing Alliance, Inc. (MAAL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

The Marketing Alliance, Inc. operates as a wholesale distributor of life insurance, annuities, and other financial service products in the USA. It provides support to independent insurance brokerage agencies, with the aim of providing members value-added services on a more efficient basis than they can attain individually. Incorporated in 1996, The Marketing Alliance has its corporate headquarters in St. Louis, Missouri. The Company lists on the OTC Markets.

The Marketing Alliance also owns an earth moving and excavating (construction) business and six children’s play and party facilities. It operates family entertainment space in the States of Florida, Illinois, Missouri, and North Carolina under the name of Monkey Joes. Moreover, the Company provides construction, heavy equipment, as well as trenching services in the States of Iowa.

Fundamentally, The Marketing Alliance is a wide-ranging network of independent agencies (product distributors) whose goals are to maximize their profit and grow their business. Regarding insurance, members of The Marketing Alliance use affiliation as it allows them to concentrate resources on opportunities with bigger pay-offs. This is while broadening offerings to producers.

Via The Marketing Alliance, affiliates have a larger presence with more contracts, better contracts, underwriting support, marketing services, competition services, and administrative support and also increased independence and a minimized need for staff. The Marketing Alliance enables smaller agencies to offer services like the biggest agencies. Moreover, the Company enables the biggest agencies to become more efficient and agile.

The Marketing Alliance previously announced that its Board of Directors declared a $0.05 per share cash dividend for shareholders of record on June 19, 2020, to be paid on or about June 30, 2020. In addition, the Company announced a change in its shareholder distribution plan to move to declare dividend distributions on a quarterly basis to have the benefit of the most recent information to make these decisions.

Mr. Timothy M. Klusas, The Marketing Alliance’s Chief Executive Officer, said, "We know dividends are an important component of investment return to our shareholders. We also felt the most responsible plan, given the current uncertainty surrounding economic conditions following the onset of the COVID-19 pandemic, was to move our planned distributions to a quarterly basis.”

The Marketing Alliance, Inc. (MAAL), closed Friday’s trading session at $5.4, up 19.7339%, on 8,845,225 volume. The average volume for the last 3 months is 8,101 and the stock's 52-week low/high is $2.26/$5.00.

OriginClear (OCLN)

QualityStocks, StocksToBuyNow, SmallCapRelations, NetworkNewsWire,, MoneyTV, SeriousTraders, MarketBeat, Promotion Stock Secrets and StockTips reported earlier on OriginClear (OCLN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

OriginClear (OCLN) leads the self-reliant water revolution, deploying advanced technologies at the point of use, with modular, prefabricated systems that create durable assets and water independence for industry, commerce and agriculture.

Systems installed at the point of use become productive assets for businesses that also increase property values. And OriginClear helps corporations improve their environmental, social and governance (ESG) standings with world-class water management.

Operations & Markets

OriginClear leads a new generation of water companies that focus on meeting the needs of businesses looking for compact, advanced technologies that can be shipped to and installed at the point of use. The company manufactures and distributes its professional-grade water treatment and conveyance products to commercial and industrial properties, fielding both direct and indirect sales channels to reach end-market clients such as hotels and resorts, real estate housing developments, office buildings, military installations, schools, farms, food and beverage manufacturers, industrial warehouse, oil and gas producers, and medical and pharmaceutical facilities.

From its Texas-based factory, OriginClear designs and prefabricates an entire line of plug-n-play containerized units called Modular Water Systems™ that enable water purification, recycling and wastewater management.

These onsite modular products provide clients with water independence through ownership and operational control over water quality, enabling them to increase productivity while reducing environmental, health and safety risks from pollution, contamination and corrosion. Modular water products are trusted to balance performance with cost-effectiveness, enabling business users to go well beyond municipal standards for water quality, therefore achieving high levels of satisfaction for their own customers, and improved sustainability for their properties.

OriginClear's water treatment equipment can boost real estate asset value as a fundamental capital improvement, combined with long-lasting water savings for the corporate bottom line.

OriginClear (OCLN), closed Friday’s trading session at $9.93, up 24.4361%, on 412,693 volume. The average volume for the last 3 months is 583,884 and the stock's 52-week low/high is $0.0192/$0.17.

Teligent (TLGTQ)

Profitable Trader Authority, StockMarketWatch, TraderPower, PennyStockScholar, OTCtipReporter, MarketBeat, BUYINS.NET, Zacks, StreetInsider, Short Term Wealth, Seeking Alpha, Schaeffer's, QualityStocks, MarketClub Analysis and reported earlier on Teligent (TLGTQ), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Teligent Inc. (NASDAQ: TLGT) (FRA: 01GA) is a specialty generic pharmaceutical firm which is focused on the development, manufacture, marketing and sale (under its own label) of branded generic, generic injectable and generic topical pharmaceutical products such as ointments and creams, in Canada and the United States.

Teligent Inc. has its headquarters in Buena, New Jersey and was incorporated in 1977 by Jane E. Hager. Before changing its name in 2015 to Teligent Inc., the firm was known as IGI Laboratories Inc. The firm markets its products in the United States.

The firm offers contract manufacturing and business development services which include the development, manufacture, filling and packaging of topical liquid and semi-solid products to generic and branded pharmaceutical customers as well as to the cosmetic and over-the-counter markets.

Teligent Inc. provides generic pharmaceutical products in ophthalmic, complex, injectable and topical dosage forms. The firm’s topical liquid and semi-solid products are utilized in various applications, ranging from cosmeceuticals and cosmetics to prescription treatments for conditions like eczema, psoriasis and dermatitis. Teligent Inc.’s product portfolio consists of topical solutions, such as Xylocaine and Pennsaid; ointments, such as Kenalog and Topicort; lotions like Kenalog, and creams such as Spectazole and Synalar. The firm sells its products through group purchasing organizations, distributors, drug wholesalers and national chain drug stores.

Teligent Inc. announced in January of 2021 that they’d be implementing a series of strategic actions that would help enhance and recapitalize the firm’s financial flexibility. This move would allow Teligent Inc. to evaluate additional strategic paths that would best position the firm for growth in the future, while also allowing them to continue delivering quality products for their patients and consumers.

Teligent (TLGTQ), closed Friday’s trading session at $1.08, up 13.6842%, on 1,545,182 volume. The average volume for the last 3 months is 2.041M and the stock's 52-week low/high is $0.02/$1.60.

REMSleep Holdings (RMSL)

Wall Street Mover, QualityStocks and PoliticsAndMyPortfolio reported earlier on REMSleep Holdings (RMSL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

REMSleep Holdings Inc. (OTC: RMSL) is engaged in designing, developing, manufacturing and distributing medical products and devices that are used to treat sleep apnea and other respiratory conditions across the globe.

The company has its headquarters in Orlando, Florida and was incorporated in 2007 on June 6 by Tom Wood and Russell Bird. The firm serves medical associations, hospitals, medical groups, physicians, product end users, internet providers, private sleep labs as well as home care dealers.

The firm is focused on offering comfort and optimum compliance for continuous positive airway pressure patients, commonly known as CPAP patients. Before this, the enterprise was a mineral development, exploration and acquisition company, that focused mainly on gold properties. By the end of December 31, 2015, the company had not generated revenues.

Currently, the firm’s product portfolio includes the DeltaWave interface, which helps dry the sinuses, causes no work of breathing, isn’t claustrophobic and doesn’t affect normal breathing mechanics. The firm’s other products include a nasal-pillows type interface that treats sleep apnea patients called DeltaWave and the DeltaWave CPAP interface, which has been designed to address the issues that affect an individual’s ability to comply with their treatment. It also helps treat patients suffering from sleep apnea.

As of November 2020, the company had launched bio testing requirements for its DeltaWave Nasal Pillow Mask. This was after it received office action from the U.S. Patent and Trademark Office concerning the aforementioned product. They plan to enter the market later in 2021, which will be beneficial to not only the firm but also its shareholders.

REMSleep Holdings (RMSL), closed Friday’s trading session at $6.36, up 19.774%, on 1,218,821 volume. The average volume for the last 3 months is 25.661M and the stock's 52-week low/high is $0.0012/$0.0472.

Oculus VisionTech, Inc. (OVTZ)

QualityStocks, UltimatePennyStock, The Street, The Online Investor, Profit Status and InvestorPlace reported earlier on Oculus VisionTech, Inc. (OVTZ), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Oculus VisionTech, Inc. is a cyber security company listed on the OTC Markets. It creates systems for document and multimedia protection to fight tampering and digital piracy. The Company was established by experts in image processing and is operated by an experienced management team. Oculus VisionTech has its corporate office in Vancouver, British Columbia. The Company previously went by the name USA Video Interactive Corp. It changed its name to Oculus VisionTech, Inc. in January of 2012.

The Company has created a Cloud-based document protection system based on embedded digital watermarking. It has done so utilizing proprietary technology originally created for embedding digital watermarking video-on-demand (VOD) systems. Oculus VisionTech’s systems, services, and delivery solutions include document, still image and motion video digital watermark solutions and documents, photographs (still image) and video content protection.

Oculus is recognized as one of the leaders in forensic watermarking. Technology such as Anti-Tampering have been pioneered as part of its efforts to remain a leader in forensic watermarking. At present, the Company is promoting the imaged-based Document Protection System (DPS) and developing a number of other products.

Oculus has developed Document Watermarking Protection technology. It is provided as a Cloud service – Cloud DPS. The Cloud DPS is a system made to protect and authenticate digital documents from tampering. It is meant for documents at the end of the editing cycle.

Previously, Oculus VisionTech announced that it has expanded its technology reach into the global data privacy compliance market. Through the recent acquisition of OCL Technologies Corporation (OCLT) of San Diego, California, Oculus will help organizations around the world to manage and monitor their data privacy compliance obligations to meet EU GDPR, CCPA, SB220 and other upcoming international privacy rights initiatives and legislation.

In addition, Oculus VisionTech previously reported the appointment of Mr. Fabrice Helliker as a Director to the Company. Mr. Helliker is presently an advisor to OCL Technologies Corp., which was recently acquired by Oculus. He is a long time executive and entrepreneur in the data protection and compliance market.

Oculus VisionTech, Inc. (OVTZ), closed Friday’s trading session at $2.1, up 10.5263%, on 3,172,353 volume. The average volume for the last 3 months is 1.347M and the stock's 52-week low/high is $0.207/$1.63.

Bespoke Extracts, Inc. (BSPK)

We reported earlier on Bespoke Extracts, Inc. (BSPK), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Bespoke Extracts, Inc. is a producer of high quality, flavorful, hemp-derived cannabidiol (CBD) extract products. The Company established in early 2017 to introduce a proprietary line of premium quality, all-natural CBD products in the form of tinctures and capsules for the nutraceutical and veterinary markets. Bespoke Extracts is headquartered in Sunny Isles Beach, Florida. The Company’s shares trade on the OTC Markets Group’s OTCQB.

The Company’s products are marketed as dietary supplements and distributed through the Company’s direct-to-consumers e-commerce store. Bespoke’s products are produced using pure, all natural, zero-THC phytocannabinoid-rich (PCR) hemp-derived CBD. CBD is non-psychoactive. CBD (cannabidiol) is one of over 85 cannabinoids found in cannabis. CBD is present in more significant quantities in hemp than it is marijuana.

Bespoke Extracts’ mission is to become one of the world’s most trusted sources for premium quality, all-natural, USA-grown, hemp-derived cannabidiol (CBD) products for the nutraceutical and veterinary markets. The Company strives to use only vegan, Fair Trade Certified, and organic ingredients with fast acting benefits for anyone looking for an alternative remedy. Bespoke’s farmers have been innovators in hemp agriculture, farming practices, agrotech, as well as production for generations. Bespoke’s hemp is stable, high in CBD, low in THC, and resistant to pathogens and pests.

The Company’s products include Sport Lemon Lime Tincture – THC Free 1500MG; CBD Manuka Honey Tincture; and CBD Bacon Flavored Pet Tincture. Moreover, products include CBD Softgel Capsules; CBD Pain Relief Cream; and CBD Isolate Powder.

Bespoke Extracts announced this past November that its Board of Directors appointed Niquana (Nikki) Noel as President and Chief Executive Officer (CEO), effective immediately. Serving Bespoke as its Operations Manager, Noel assumed day-to-day leadership of the Company and joined its Board of Directors. Noel has spent close to two decades working with privately-held and publicly-traded micro and small cap companies.

Bespoke Extracts, Inc. (BSPK), closed Friday’s trading session at $22.07, up 13.8216%, on 2,623,918 volume. The average volume for the last 3 months is 13.893M and the stock's 52-week low/high is $0.0085/$0.10165.

LogicBio Therapeutics (LOGC)

MarketBeat, StockMarketWatch, QualityStocks and SmallCap Fortunes reported earlier on LogicBio Therapeutics (LOGC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

LogicBio Therapeutics, Inc. (NASDAQ: LOGC) (FRA: 0IF) is a genome-editing firm whose focus is to develop medicines aimed at treating patients that have unmet medical needs through harnessing the power of genome editing. The company was founded in 2014 and has its headquarters in Lexington, Massachusetts.

The enterprise has a proprietary gene editing platform known as GeneRide, which is programed to integrate corrective genetic material into patients’ genomes in order to avail a stable medicinal effect. The firm is currently focusing its research efforts into developing products for treating rare liver ailments in pediatric patients.

Its extensive product pipeline includes LB-001 indicated for Methylmalonic Acidemia, LB-101, indicated for the treatment of hemophilia B., and LB-201 developed to treat alpha-1-antitrypsin deficiency. The company is also developing another product dubbed LB-301 which is intended to treat various forms of Crigler-Najjar syndrome in veterinary patients.

LogicBio also owns another platform dubbed sAAVy. This proprietary platform is for delivering gene capsids. The platform was designed to address the shortcomings associated with older versions of gene capsid platforms. sAAVy brings increased safety and boosts the potency of the treatments administered.

The firm has research collaboration agreements with CANbridge Care Pharma in Hong Kong, Daiichi Sankyo Ltd., and another with Takeda Pharmaceutical Company Ltd. All these collaborations are aimed at accelerating the development and commercialization of the product candidates of LogicBio in its fight against rare genetic diseases, especially those affecting children.

The company recently announced early positive findings from its phase 1/2 clinical trials testing the firm’s LB-001 product candidate. The study successfully demonstrated that it was possible to undertake gene editing in vivo. This finding is the first ever such proof, and the company is hopeful that LB-001 will complete the remaining phases of clinical development and secure eventual approval for use in treating patients.

LogicBio Therapeutics (LOGC), closed Friday’s trading session at $3.96, off by 2.4631%, on 892,216 volume. The average volume for the last 3 months is 50,605 and the stock's 52-week low/high is $3.60/$9.745.

The Beachbody Company (BODY)

SmarTrend Newsletters, Gryphon Digest, The Street, StreetInsider, Barchart, TradingMarkets, PennyOmega, Hit and Run Candle Sticks, Schaeffer's, MarketBeat, StreetAuthority Daily, DrStockPick, Dynamic Wealth Report, Dividend Opportunities, CRWEWallStreet, FNNO Newsletters, CRWEFinance, InvestorPlace, InvestorTrendz, Millennium-Traders, PennyToBuck, QualityStocks, StockHotTips, Street Insider, TheStockAdvisor and Louis Navellier reported earlier on The Beachbody Company (BODY), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

The Beachbody Company Inc. (NYSE: BODY) is a holding firm that operates a health and wellness platform which offers stress-reducing, nutrition and fitness programs.

The firm has its headquarters in Santa Monica, California and was incorporated in 1998 by Jon Congdon and Carl Daikeler. The firm serves consumers around the globe.

The company operates through two segments and has more than two decades of experience creating innovative content. It has developed a fitness digital streaming platform with a content library that contains more than 2300 streaming workouts and roughly 80 complete workout programs.

The enterprise operates various digital platforms, which include a digital subscription platform known as Beachbody on Demand, which offers access to the company’s library of on-demand and live nutrition and fitness content. Its other digital streaming platform; Openfit, offers digital wellness and fitness resources. It also operates its connected fitness brand, known as Myx fitness. The enterprise’s digital subscriptions include free-to-pay and paid subscriptions. In addition to this, it provides nutritional products, which include Collagen, Bevvy- its low sugar protein bars, its Beachbody performance supplements, which contain a pre-workout, post-workout and recovery recharge products; and a once daily premium nutrition shake known as Shakeology. The enterprise’s other brands include Beachbody Performance and Ladder.

The company recently launched BODi, its live interactive premium subscription tier, which brings the energy and experience of a fitness class into the homes of Beachbody members. This product will not only extend the company’s consumer reach but also encourage more investments into the company, which will have a positive influence on the company’s growth.

The Beachbody Company (BODY), closed Friday’s trading session at $0.4815, up 0.3125%, on 2,261,268 volume. The average volume for the last 3 months is 748,822 and the stock's 52-week low/high is $4.75/$18.20.

China Pharma (CPHI)

Wall Street Resources, StockMarketWatch, QualityStocks, MarketBeat, TradersPro, The Street, Promotion Stock Secrets, PoliticsAndMyPortfolio, PennyOmega, InvestorsUnderground, InvestorPlace, Greenbackers, China Vesting and BUYINS.NET reported earlier on China Pharma (CPHI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

China Pharma Holdings Inc. (NYSE American: CPHI) (FRA: XQJ) is a pharmaceuticals firm that is focused on the development, manufacture and marketing of branded and generic biochemical and pharmaceutical products.

The firm has its headquarters in Haikou, the People’s Republic of China and was incorporated in 1999, on January 28th by Zhi Lin Li. The firm serves consumers in China.

The company is focused on developing pharmaceutical products for human use in connection with various high-mortality and high-incidence medical conditions and illnesses in China. It provides its products in the form of capsules, tablets, liquid injectables, dry powder injectables and oral solutions. The company provides its products through its network of sales offices and representatives as well as through distributors.

The enterprise’s products include its Andrographolide product indicated for the treatment of sore throat brought about by an upper respiratory tract infection; Roxithromycin dispersible tablets for tonsillitis and pharyngitis; Alginic Sodium Diester injection for high lipoprotein blood, cerebrovascular and ischemic heart diseases; Gastrodin injection, indicated for traumatic syndromes of the brain, poor sleep, loss of concentration and tiredness; a Candesartan product for hypertension; and Bumetanide, which has been developed to treat edema ailments. In addition to this, the enterprise also develops an injection dubbed Granisetron Hydrochloride for the treatment of vomiting and nausea caused by chemotherapy and radiotherapy.

The firm is focused on accelerating its growth in Traditional Chinese Medicine and specialty pharma, which it believes will position them for considerable growth and afford them opportunities to expand into new markets as well as grow.

China Pharma (CPHI), closed Friday’s trading session at $2.22, up 7.2464%, on 4,237,155 volume. The average volume for the last 3 months is 1.539M and the stock's 52-week low/high is $0.37/$1.63.

BIMI International Medical (BIMI)

StockMarketWatch, MarketClub Analysis, TradersPro, StreetInsider, Real Pennies, QualityStocks, TradersPro Morning, TopPennyStockMovers, TheMicrocapNews,, OilAndEnergyInvestor and InvestorsUnderground reported earlier on BIMI International Medical (BIMI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

BIMI International Medical Inc. (NASDAQ: BIMI) (FRA: 63N) is a company engaged in the wholesale and retail distribution of pharmaceutical products, medical devices and other healthcare products.

The firm has its headquarters in Chongqing, the People’s Republic of China and was incorporated in 2000, on October 31st. Prior to its name change in June 2021, the firm was known as Boqi International Medical Inc. The firm serves consumers in China.

The company is locally focused and community-based, engaging its consumers with seamless, simple, accessible and more affordable care when and where they need it. It hopes to establish a chain of hospitals specializing in gynecology and obstetrics in the future.

The enterprise provides an extensive range of consumer-directed health products and related services, which include health information technology services and products, chronic disease management services, behavioral, pharmacy and medical health plans. It also provides over-the-counter and prescription drugs, health foods, nutritional supplements and sundry products, as well as personal and family care products, traditional Chinese medicines and miscellaneous items. It offers these products under the Lijiantang Pharmacy brand. In addition to this, the enterprise offers research and development services. It sells medications and other healthcare products to consumers directly through its directly owned stores.

The company is set to acquire Zhuoda Pharmaceutical Co. Ltd, which supplies pharmaceuticals and medical equipment on wholesale basis. This move will allow the company to expand its product coverage as well as generate shareholder value, which will have a positive effect on the company’s investments, as well as on its growth.

BIMI International Medical (BIMI), closed Friday’s trading session at $5.32, up 0.948767%, on 454,602 volume. The average volume for the last 3 months is 4.651M and the stock's 52-week low/high is $0.53/$2.81.

Affimed NV (AFMD)

MarketBeat, MarketClub Analysis, StockMarketWatch,, PoliticsAndMyPortfolio, BUYINS.NET, StreetInsider, Schaeffer's, Trading Concepts, TradersPro, QualityStocks, Barchart, Investment U, InvestorPlace, OTCtipReporter, PennyStockProphet, Profitable Trader Authority, Wall Street Mover, Stock Beast, The Online Investor and PennyStockScholar reported earlier on Affimed NV (AFMD), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Affimed NV (NASDAQ: AFMD) is a clinical-stage biopharmaceutical firm that is engaged in the discovery and development of cancer immunotherapies.

The firm has its headquarters in Heidelberg, Germany and was incorporated in 2000. Prior to its name change in October 2014, the firm was known as Affimed Therapeutics B.V. It serves consumers around the globe, with a focus on Germany, Europe and the United States. The firm generates the majority of its revenue from the United States.

The company is party to collaboration agreements with Roche Holding AG, Roivant Sciences Ltd, Genentech Inc., and the University of Texas MD Anderson Cancer Center. It also has a research funding agreement with the Leukemia & Lymphoma Society. The company is focused on providing a unique approach to fighting cancer using its scientific team, which has extensive expertise in immunity and cell engager-based medicines. Its objective is to overcome the challenges and limitations faced by the current immune-oncology therapies.

The enterprise’s product portfolio comprises of its AFM13 formulation, which in different phases of clinical trials evaluating its effectiveness in treating transformed mycosis fungoides, peripheral T-cell lymphoma, hodgkin lymphoma and CD30-positive T-cell lymphoma. It also develops a cell-engaging bi-specific antibody formulation dubbed AFM26, for the treatment of multiple myeloma, as well as its AFM24 formulation, which has been developed to treat advanced cancers.

The company is focused on progressing its parallel development strategy for some of its formulations and advancing its broad development pipeline, which it expects will generate an ongoing stream of data over the coming quarters.

Affimed NV (AFMD), closed Friday’s trading session at $1.71, off by 2.8409%, on 156,066 volume. The average volume for the last 3 months is 1.958M and the stock's 52-week low/high is $3.085/$11.74.

LendingClub Corporation (LC)

MarketClub Analysis, InvestorPlace, Schaeffer's, The Street, StreetInsider, MarketBeat, StocksEarning,, Daily Trade Alert, StreetAuthority Daily, Jason Bond, Barchart, Kiplinger Today, Shah's Insights & Indictments, TradersPro, BUYINS.NET, Street Insider, Market Report, Daily Profit, Trades Of The Day, CNBC Breaking News, Wealth Insider Alert, TopStockAnalysts, Daily Wealth, Investopedia, Wall Street Daily, Profitable Trader Authority, Money Morning, Average Joe Options, CB Insights, Investing Daily, OTCtipReporter, Hit and Run Candle Sticks, Greenbackers, ChartAdvisor, Investing Futures, Rick Saddler, Wyatt Investment Research, Uncommon Wisdom, Trading Concepts, Total Wealth, The Trading Report, The Stock Dork, The Online Investor, OilAndEnergyInvestor, StockMarketWatch, Louis Navellier, ProfitableTrading, PennyStockScholar, Zacks, One Hot Stock, AllPennyStocks, MarketWatch, Market FN and The Best Newsletters reported earlier on LendingClub Corporation (LC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Shares of LendingClub Corporation (NYSE:LC) traded at a new 52-week high today of $46.15. This new high was reached on approximately average trading volume as 2.4 million shares traded hands, while the average 30-day volume is approximately 2.5 million shares.

Potential upside of 127.2% exists for LendingClub Corporation, based on a current level of $45.95 and analysts' average consensus price target of $104.41.

LendingClub Corp is a company engaged in operating an online lending marketplace platform that connects borrowers and investors for the provision of the loan facility. It offers investors access to an asset class that has generally been closed to many investors and only available on a limited basis to institutional investors. The company through the platform offer loan products such as personal, education and patient finance, small business and auto to interested investors. It generates a majority of the revenue from the transaction fees received from the platform's role in accepting and decisioning applications on behalf of the bank partners to enable loan originations.

In the past 52 weeks, shares of LendingClub Corporation have traded between a low of $4.40 and a high of $46.15 and is now at $45.95, which is 944% above that low price.

LendingClub Corporation (LC), closed Friday’s trading session at $35.48, up 31.3101%, on 377,220,883 volume. The average volume for the last 3 months is 7.673M and the stock's 52-week low/high is $4.40/$46.9199.

The QualityStocks Company Corner

Net Element (NASDAQ: NETE)

The QualityStocks Daily Newsletter would like to spotlight Net Element (NETE).

Electric vehicles aren’t just a hobby for car enthusiasts or rich people who have extra cash to burn. EVs are poised to become the dominant form of vehicular transportation over the next couple of decades, and several countries around the world have avowed their commitment to electrify their roads. Even though the percentage of the globe’s cars that are electric is still quite small, more and more people are buying electric cars or considering buying EVs in the future. According to a new study by Peugeot UK, interest in these zero-emission vehicles isn’t limited to the older generations; kids are curious about EVs as well, and they are talking to their parents about it. If these survey findings reflect the views of the public in different markets, then companies such as Net Element (NASDAQ: NETE) are likely to see increasing levels of receptiveness to EVs as the years go by.

On June 15, 2020, Net Element announced its entry into a binding letter of intent to merge with privately-held Mullen Technologies Inc., a Southern California-based electric vehicle company, in a stock-for-stock reverse merger in which Mullen’s stockholders will receive the majority of the outstanding stock in the post-merger company. The proposed merger is currently pending the execution of a definitive agreement, shareholder vote and regulatory approval.

Net Element Inc. (NASDAQ: NETE) is a global financial technology and value-added solutions group that supports electronic payments acceptance in an omni-channel environment spanning across point-of-sale, e-commerce and mobile devices. The company operates a payments-as-a-service transactional model and value-added services platform for small to medium enterprises in the U.S. and selected emerging markets.

Net Element believes the future of global commerce is being revolutionized as consumers quickly migrate toward omni-channel shopping utilizing mobile devices, desktop, and online services. The company’s all-in-one payment solutions support and unify a whole range of applications through a single, robust platform, allowing global onboarding and support for multiple payment methods.

Net Element has also launched a blockchain-focused business unit that will develop and deploy blockchain technology-based solutions. Net Element expects the new division to create a decentralized crypto-based ecosystem that will act as a framework for an unlimited number of value-added services, connecting merchants and consumers in a seamless, economically efficient transaction. This new business unit intends to also identify and invest in unique projects that decentralize and disrupt the payment processing industry by combining blockchain technology and real-world applications with talented development teams, strong fundamentals and addressable markets large in size.

“We believe that we’re at the dawn of a new evolution where additional digital payment methods are being introduced,” Net Element chairman and CEO Oleg Firer, says. “Introduction of our division focused on blockchain as part of the NASDAQ-listed entity will add transparency and compliance assurance to our investors as well as provide access to deploy value-added services to over 20 million electronic commerce clients that are currently part of Net Element’s growing network.”

Net Element clients are treated to customized solutions that provide the flexibility needed to keep up with customers. Among the services offered are mobile payment apps that accept payments anywhere, anytime; cloud-based solutions built to increase productivity and enhance revenue for clients and partners; marketing solutions that turn lookers into buyers; and business analytics that make it easy for clients to monitor business metrics, engage with customers and compare the competition. Its multi-channel platform combines e-commerce, offline, point-of-sale, comprehensive back office tools, mobile point-of-sale, credit scoring and customer interaction in one powerful platform-as-a-service technology.

Net Element owns and operates a global mobile payments and transactional processing provider, TOT Group, Inc., with the following subsidiaries:

  • Unified Payments – An award-winning, customized mobile billing and payments solution, recognized by Inc. Magazine as the No. 1 Fastest Growing Company in America in 2012.
  • Aptito – A next-generation, all-in-one, cloud-based restaurant management and point-of-sale payments platform using wireless technology.
  • Payonline – A fully integrated, processor agnostic electronic commerce platform.

Net Element is ranked on Deloitte’s Technology Fast 500™ list of North America’s 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies in both 2017 and 2018, during which the company grew 190 percent and 183 percent, respectively. The company credits its progression to organic growth in its North America Transactions Segment, specifically the success of its Unified Payments brand, which focuses on value-added payment acceptance solutions for small to medium enterprises in the United States.

Net Element was also listed among South Florida Business Journal’s 2016 fastest growing technology companies.

Leveraging its suite of application performing interfaces (APIs) and connectors, Net Element powers commerce for businesses of all sizes through multi-channel platforms, all-in-one digital solutions, and end-to-end encryption of cardholder data utilizing tamper resistant hardware that ensures integrity and simplifies security.

Leading this innovation is chairman and CEO Oleg Firer, who is responsible for the overall vision, strategy and execution of the company’s mission of powering global commerce. He is joined by CFO Jeffrey Ginsburg, CPA, and Steven Wolberg, the company’s chief legal officer and secretary. Each corporate officer brings a unique blend of leadership, vision, experience and creative energy to the company.

From mobile payments and value-added transactional innovations like Aptito to e-commerce and retail payment transaction processing brands like Payonline and Unified Payments, Net Element is transforming the online and mobile experience.

Net Element (NETE), closed Friday’s trading session at $0.045, off by 3.0172%, on 770,363 volume. The average volume for the last 3 months is 627,188 and the stock's 52-week low/high is $5.68/$19.15.

Recent News

Lexaria Bioscience Corp. (NASDAQ: LEXX)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (NASDAQ: LEXX).

Lexaria Bioscience Corp. (NASDAQ: LEXX) was recently part of coverage by Zacks Small-Cap Research analysts based on its market potential. Zacks, which focuses its coverage on small and micro-cap companies it regards as under-followed or under-valued by the broader market in an effort to benefit investors as well as worthy innovators, valued the company at $15 per share. The valuation was based on the company’s portfolio supporting Lexaria’s patented DehydraTECH(TM) consumption and the multiple potential uses of the technology. The technology is also relatively low-cost, with the capacity to produce up to 400,000 consumer packaged goods through existing manufacturer relationships. A recent article reads, “Zacks notes the potential market reach of Lexaria’s technology if regulatory approved for use in pharmaceuticals, given that hypertension affects about 150 million people nationwide and over a billion worldwide, many of whom find existing medicines less than optimal. The ongoing COVID pandemic has also heightened attention on the need for antivirals to treat ever-present virus infections. And there are about a billion smokers worldwide who could potentially benefit from alternative methods of delivering nicotine to avoid the lung-deleterious effects of inhaling burned or vaporized substances.” To view the full article, visit:

Lexaria Bioscience Corp. (NASDAQ: LEXX) is a global innovator in drug delivery platforms. The company’s patented technology, DehydraTECH™, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting healthier oral ingestion methods and increasing the effectiveness of fat-soluble active molecules.  DehydraTECH promotes fast-acting, less expensive and more effective oral drug delivery and has been thoroughly evaluated through in vivo, in vitro and human clinical testing.

DehydraTECH is covered by 21 issued and more than 50 pending patents in over 40 countries around the world. Lexaria’s first patent was issued by the U.S. Patent and Trademark Office in October 2016 (US 9,474,725 B1), providing 20 years of patent protection expiring June 2034. Multiple patents have been awarded since then and are expected in the future.

Lexaria has a collaborative research agreement with the National Research Council (NRC), the Canadian government’s premier research and technology organization. The company has filed for patent protection for specific delivery of nicotine, vitamins, NSAIDs, testosterone, estrogen, cannabinoids, terpenes, PDE5 inhibitors (with brand names like Viagra), tobacco and more.

Lexaria began developing DehydraTECH in 2014 and has since continued to strengthen and broaden the technology. The company has no plans to create or sell Lexaria-branded products containing controlled substances. Instead, Lexaria licenses its technology to other companies around the world to offer consumers the best possible performance across an array of ingestible product formats.

The company’s technology is best thought of as an additional layer that providers of consumer supplements, prescription and non-prescription drugs, nicotine and CBD products can utilize to improve the effectiveness of their own existing or planned new offerings. Lexaria has licensed DehydraTECH to multiple companies, including a world-leading tobacco producer for the research and development of smokeless, oral-based nicotine products, and for use in industries that produce cannabinoid beverages, edibles and oral products.

DehydraTECH is suitable for use with a wide range of product formats including pharmaceuticals, nutraceuticals, consumer packaged goods and over-the-counter capsules, pills, tablets and oral suspensions.

DehydraTECH Technology

Lexaria’s DehydraTECH is designed specifically for formulating and delivering lipophilic (fat-soluble) drugs and active ingredients. DehydraTECH increases their effectiveness and improves the way active pharmaceutical ingredients enter the bloodstream. The major benefits to a subject ingesting a DehydraTECH-enabled drug or consumer product can be summarized by the following:

  • Speeds up delivery – the effects of the product are felt by the subject in just minutes.
  • Increases bioavailability – the technology is much more effective at delivering a drug or product into the bloodstream.
  • Increases brain absorption – animal testing suggests significant improvement in the quantity of drug delivered across the blood-brain barrier.
  • Improves drug potency – more of the ingested product is made available to the body, so lower doses are required to achieve the desired effect.
  • Reduces drug administration cost – lower doses mean lower overall drug costs.
  • Masks unwanted taste – the technology eliminates or reduces the need for sweeteners.

Lexaria has demonstrated in animal studies a propensity for DehydraTECH technology to elevate the quantity of drug delivered across the blood-brain barrier by as much as 1,900 percent, initiating additional new patent applications and opening possibilities for improved drug delivery.

Since 2016, DehydraTECH has repeatedly demonstrated, with cannabinoids and nicotine, the ability to increase bio-absorption by up to five to 10 times, reduce time of onset from one to two hours to just minutes, and mask unwanted tastes. The technology is to be further evaluated for additional orally administered bioactive molecules, including antivirals, cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs) and nicotine.

Market Outlook

Lexaria’s ongoing research and development efforts are mainly focused on development of product candidates across several key segments:

  • Oral Cannabinoids – a market estimated to be worth $18.4 billion in 2021 and expected to reach $46.2 billion by 2025.
  • Antivirals – an estimated $52.1 billion market in 2021 that’s expected to grow to $66.7 billion by 2025.
  • Oral Mucosal Nicotine – smokeless tobacco products, a $13.6 billion market in 2018, is forecast to grow at 7.2 percent annually through 2025.
  • Human Hormones – estrogen and testosterone replacement therapies represented a $21.9 billion market in 2019, with a forecast CAGR of 7.7 percent through 2027.
  • Ibuprofen and Naproxen – NSAID sales totaled $15.6 billion globally in 2019 and are projected to reach $24.4 billion by 2027.
  • Vitamin D3 – the global market size was $1.1 billion in 2021, growing at 7 percent per year and expected to reach $1.7 billion in 2026.

Management Team

Chris Bunka is Chairman and CEO of Lexaria Bioscience Corp. He is a serial entrepreneur who has been involved in several private and public companies since the late 1980s. He has extensive experience in the capital markets, corporate governance, mergers and acquisitions, as well as corporate finance. He is named as an inventor on multiple patent innovations.

John Docherty, M.Sc., is the President of Lexaria. He is a pharmacologist and toxicologist, and a specialist in the development of drug delivery technologies. He is the former president and COO of Helix BioPharma Corp. (TSX: HBP). He is named as an inventor on multiple issued and pending patents.

Greg Downey is Lexaria’s CFO. He has more than 35 years of diverse financial experience in the mining, oil and gas, manufacturing, and construction industries, and in the public sector. He served for eight years as CFO for several public companies and has provided business advisory and financial accounting services to many large organizations.

Gregg Smith is a strategic advisor to Lexaria. He is a founder and private investor with Evolution VC Partners. He is a member of the Sand Hill Angels and held previous investment banking roles with Cowen and Company and Bank of America Merrill Lynch.

Dr. Philip Ainslie serves as a scientific and medical advisor to Lexaria. He is co-director for the Centre for Heart, Lung and Vascular Health, Canada. He is also Research Chair in Cerebrovascular Physiology and Professor at the School of Health and Exercise Sciences, Faculty of Health and Social Development at the University of British Columbia.

Lexaria Bioscience Corp. (LEXX), closed Friday’s trading session at $0.0631, off by 11.8715%, on 40,000 volume. The average volume for the last 3 months is 59,265 and the stock's 52-week low/high is $3.9751/$12.50.

Recent News

AmpliTech Group Inc. (NASDAQ: AMPG)

The QualityStocks Daily Newsletter would like to spotlight AmpliTech Group Inc. (AMPG).

AmpliTech Group (NASDAQ: AMPG), a designer, developer and manufacturer of state-of-the-art, signal-processing components for satellite and 5G communications networks, defense, space and other commercial applications, plans to move its manufacturing and headquarters operations into a new 20,000 square-foot facility located in Hauppauge, New York. The company has signed an initial seven-year lease on the property. The company, whose present facility measures 13,100 square feet, observed that the new facility allows AMPG to bring together its design, engineering, and sales and marketing teams together under one roof, a move that will support greater collaboration and operational efficiency; the move, which is slated to be complete by Q1 2022, also provides significant room for growth. “It has been our goal to consolidate our two Long Island locations into a new and enhanced, purpose-driven facility built around our needs,” said AmpliTech Group CEO Fawad Maqbool in the press release. “There, we expect to benefit from an enhanced customer experience, greater collaboration across our business units and improved economies of scale, while also providing an expanded footprint for both internal and external growth. The near-term completion of this effort represents another important step in our vision to expand AmpliTech’s growth potential and capabilities.” To view the full press release, visit

AmpliTech Group Inc. (NASDAQ: AMPG) (NASDAQ: AMPGW) designs, develops and manufactures custom radio frequency (RF) components for the commercial, SATCOM, space and military markets. In addition to developing new products for the 5G/6G wireless ecosystem and infrastructure, the company has placed focus on the development of leading-edge solutions in quantum computing in support of U.S. efforts to reach the coveted position of quantum supremacy. The company maintains a commitment to R&D that allows it to remain at the forefront of emerging technologies. AmpliTech aims to use its advanced techniques and IP to provide tomorrow’s technology today, improving everyone’s quality of life.

AmpliTech was founded by Fawad Maqbool in 2002 to fill the need for affordable, high-quality, customized and state-of-the-art amplifiers and components. Headquartered in Bohemia, New York, the company currently has distributors and representatives available worldwide.

Product Portfolio

AmpliTech’s mission is to develop quality, state-of-the-art microwave amplifiers by leveraging its experience, proven technical expertise and superior design heritage. The company’s products cover a frequency range from 50 kHz to 44 GHz, with plans to eventually offer designs up to 100 GHz. Its current catalog includes:


Passive Components

All the company’s products come with a satisfaction guarantee, as the company is fully committed to providing only high-quality products free from manufacturing and material defects and guaranteed to perform according to applicable specifications.

Consulting Services

Leveraging more than 100 years of combined experience in microwave systems and component design ranging from active components to passive devices, AmpliTech also provides valuable consulting services and technical assistance to its customers.

With capabilities ranging from initial design to final manufacturing and delivery, the company’s team also offers project management services and advice on both technical aspects and how to handle business issues such as resource allocation, customer contact, budget restraints, time limits and more.

Other key benefits of AmpliTech consulting services that can give its customers a definitive edge include:

  • Timely technical assistance
  • Little or no learning curve
  • Less long-term costs associated with full-time employees with benefits and salaries
  • Availability when necessary
  • Customer support with schedules, project management and on the job training
  • Access to technology
  • Partnering for manufacturing and/or complete turn-key product solution
  • Personal guidance from concept to development
  • Custom designs for each application

Market Outlook

The global microwave devices market was valued at $7.44 billion in 2019 and is expected to grow at a CAGR of 3.23% and reach $9 billion by 2025 ( Governmental expenditures in the defense and space communications sectors are expected to expand the opportunities for growth within the industry.

AmpliTech continues to follow its strategy of identifying key elements in today’s technological revolution. It is leveraging its technical expertise and experience to align product portfolios and IP with innovation ( The company has plans to be a catalyst in the enhancement, development and distribution of breakthroughs in the following sizeable markets:

  • High Speed Terrestrial and Satellite Terminals (SATCOM, “Internet in the Sky”)
  • 5G/Wi-Fi6E and 6G wireless infrastructure (Cellular Base Stations, Small Cells, Private Wi-Fi Networks)
  • IoT (Internet of Things)
  • Cloud Farms, Big Data and MEC architecture
  • Quantum Supercomputers/Quantum Research
  • Deep Space Astronomy
  • Autonomous Self-Driving Vehicles
  • Telemedicine, AR/VR (Augmented and Virtual Reality)
  • Drones, UAVs (Unmanned Aerial Vehicles)
  • Cyber-security
  • Military/Defense ECM/EW

Management Team

Fawad Maqbool is the Founder, President, CEO and CTO of AmpliTech Group Inc. He has been in the microwave industry for over 30 years. Mr. Maqbool spent 14 years developing state-of-the-art amplifiers and components for MITEQ Inc., a leading microwave and communications equipment supplier. He founded AmpliComm in 2000, which was subsequently acquired by Aeroflex Inc. Mr. Maqbool has management and design experience, which has led to the development of microwave technology on a commercial and military level. He holds a B.S.E.E in Microwave Engineering and a B.S.E.E in Bio-Medical Engineering from CUNY and an M.S.E.E from the Polytechnic University of New York.

Louisa Sanfratello is the company’s CFO. She is a Certified Public Accountant (CPA) and has worked in various industries since 1998. During this time, she held roles as an accountant for charities and schools, consisting of the preparation of official financial documents and day-to-day financial management requirements. Ms. Sanfratello began her professional career in 1987 at Holtz, Rubinstein & Co., a public accounting firm. She gathered two years of experience there before gaining her CPA and taking on more challenging roles.

Brandon Worster is the company’s Director of Engineering. He joined AmpliTech at the end of 2019, bringing over 14 years of design and management experience. His specialty is Low Noise and Medium Power Amplifiers, but Mr. Worster also has vast experience with various systems, including RF/Microwave devices and systems. He holds a master’s degree in electrical engineering and is an adjunct professor at Farmingdale University in New York.

John P. Pastore is AmpliTech’s Director of Sales. He has worked in the microwave industry for more than 35 years, including time with some of the industry’s leading names. Mr. Pastore is a hands-on professional who has experience that spans over 20 years with progressive roles that blend technical, manufacturing, customer service and management expertise. He is an extremely valuable asset to the company as it moves forward due to his business savvy approach and deep industry knowledge. He has a B.S. in Business Management.

M. Syed handles Technical Sales and is the company’s Director of IT. He is an electrical engineer with more than 10 years of business experience. Since 2011, he has led Technical Sales for AmpliTech, and he recently became the President and CEO of his own company while also serving as Chief Technical Sales consultant for numerous other companies and groups in New York City. Mr. Syed has been in the IT industry for 25 years. He is a Computer Engineer by trade and a Certified Netware Engineer and Microsoft Certified Systems Engineer.

AmpliTech Group Inc. (AMPG), closed Friday’s trading session at $0.2435, up 1.4161%, on 35,800 volume. The average volume for the last 3 months is 342,144 and the stock's 52-week low/high is $1.56/$19.80.

Recent News

Vivos Therapeutics Inc. (NASDAQ: VVOS)

The QualityStocks Daily Newsletter would like to spotlight Vivos Therapeutics Inc. (NASDAQ: VVOS).

The National Institutes of Health estimates that about 25 million individuals in America suffer from obstructive sleep apnea. Obstructive sleep apnea is a common sleep disorder that causes an individual’s breathing to start and stop while they’re asleep. The disorder affects an individual’s sleep and increases their risk for accidents as well as other diseases. It has many symptoms, the most common one being loud snoring. Other symptoms include excessive irritability, sore throat, dry mouth and morning headaches. With cutting-edge treatments such as the proprietary Vivos System made by Vivos Therapeutics Inc. (NASDAQ: VVOS), the prospects of successfully treating obstructive sleep apnea have never been brighter.

Headquartered in Denver, Colorado, Vivos Therapeutics Inc. (NASDAQ: VVOS) is an emerging global leader in the treatment of mild-to-moderate obstructive sleep apnea (OSA), a debilitating condition affecting nearly 1 billion people worldwide. The company utilizes proprietary, ground-breaking technology, a proven go-to-market strategy, and a powerful executive team dedicated to changing the face of health care by helping people of all ages properly breathe and sleep.

At the core of Vivos’ mission to rid the world of mild-to-moderate OSA is the Vivos System®, a revolutionary clinical breakthrough in the treatment of mild-to-moderate sleep apnea often caused by craniofacial anatomy development. The Vivos System® multidisciplinary treatment protocol involves collaboration between physicians, specially-trained dentists who have completed advanced training in craniofacial sleep medicine, and other ancillary health care providers.

In support of its growth strategy, Vivos has established contract manufacturing facilities in the U.S., Canada and Asia.

Market & Technology Overview

Craniofacial developmental deficiencies, such as underdeveloped upper and lower jaws, are among the leading causes of OSA. According to a 2019 analysis from researchers at the University of California, San Diego, an estimated 81 million adults in North and South America suffer from moderate to severe OSA. The United States has the highest amount of these patients, with approximately 54 million adults affected, according to the report.

Registered with the FDA as a Specification Developer, Vivos develops and markets a number of oral appliances. Its technology represents the first non-surgical, non-invasive and cost-effective treatment for the estimated hundreds of millions of people globally who suffer from mild-to-moderate OSA.

Vivos integrates its specially designed, customized appliances into a patient-specific, multi-disciplinary clinical protocol, giving trained dental and medical providers the tools and roadmap needed to address certain craniofacial conditions that studies have shown to be associated with sleep-disordered breathing—including mild-to-moderate OSA.

The system’s treatment protocol involves collaboration between physicians, specially trained dentists who have received advanced training in craniofacial sleep medicine, and additional health care providers. Vivos-trained clinicians can be found in almost every major city in the U.S. and in many countries throughout the world. The company’s oral appliances have shown to be effective in over 15,000 patients successfully treated worldwide by approximately 1,200 trained dentists.

A New Paradigm in Sleep Medicine

Vivos’ proprietary system poses the potential to be the biggest breakthrough in the treatment of mild-to-moderate OSA since CPAP.

The Vivos System has been specifically designed to promote the proper growth and development of the hard and soft tissues surrounding and comprising the oral cavity, nasal cavity, upper and lower jaws, and other tissues which together form and shape the upper airway. As these areas develop more fully using the Vivos System, a patient’s airway typically widens and expands, enabling them to breathe properly through their nose. With a more open and less obstructed airway, and easier nocturnal breathing, the symptoms of SDB tend to diminish over time, and patients often report they no longer suffer from the adverse effects of SDB or OSA.

Use of the Vivos System is variable and case dependent, but typically recommended to be worn daily for 12 to 16 hours starting in the early evening and continuing overnight. The total treatment time typically ranges from 12 to 24 months, with 18 months being the approximate mean treatment time.

Biomimetic Oral Appliance

Vivos Therapeutics believes that the Vivos System technology represents the first non-surgical, non-invasive and cost-effective treatment for people with mild-to-moderate OSA.

Combining technologies and protocols that can alter the size, shape and position of the tissues of a patient’s upper airway, the Vivos System opens airway space and can significantly reduce symptoms and conditions associated with mild-to-moderate OSA.

The Vivos System treatment is typically less than $10,000 and is often reimbursable by medical insurance as an out-of-network benefit.

A potentially serious medical problem with an alternative treatment therapy available in the dental office.

Hard and soft tissues of the craniofacial complex can be non-surgically enhanced using the proprietary Vivos® System devices and clinical protocols.


R. Kirk Huntsman – CEO, Director
With experience in strategic development, technology acquisition and product planning, key talent recruitment, and target market prioritization, Huntsman brings a broad vision paired with leadership and strategic planning skills. He has significant start-up experience in a diverse range of market sectors, including medical devices, dental management, dental practice valuations and transitions, multi-location retail, financial and capital formation, consulting, outsourced services, imports and exports (China), medical services, and software and technology.

Dr. Dave Singh – Founder, Director
A doctor three times over in dental medicine, craniofacial development, and orthodontics, Dr. Singh was educated primarily in England and has lectured in North America, Europe, Asia, and Africa. The Global Summits Institute recently named Dr. Singh as one of the Top 100 Doctors in Dentistry.

Vivos Therapeutics Inc. (NASDAQ: VVOS), closed Friday’s trading session at $0.162505, up 8.3367%, on 27,305 volume. The average volume for the last 3 months is 44,327 and the stock's 52-week low/high is $2.61/$14.41.

Recent News


The QualityStocks Daily Newsletter would like to spotlight LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF).

  • Although the U.S. has yet to adopt cryptocurrency as a form of payment, other countries have begun the adoption process
  • Mastercard will be one of the first major credit card companies to convert to cryptocurrency instead of a point system. The bitcoin can be used to get airline miles, hotel stays, gift cards, and more.
  • In 2020, it was estimated that 328,370 bitcoin transactions go through each day, with approximately 15,174 businesses accepting crypto as a form of payment
  • LQwD’s Lightning Network helps to send bitcoin payments, providing quicker settlement times and fewer user fees

Since the introduction of bitcoin, cryptocurrency has been steadily increasing in popularity among users. The rise in popularity promoted an increasing number of businesses and institutions to adopt digital currencies. Even some countries, such as El Salvador, have begun accepting bitcoin as a form of currency. The market growth and increased adoption are benefitting digital payment companies such as LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF), a financial tech firm focused on creating an enterprise-grade infrastructure to drive bitcoin adoption. 

LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) is a financial technology company focused on creating enterprise-grade infrastructure to drive bitcoin adoption.

LQwD FinTech’s mission is to develop institutional-grade services that support the Lightning Network and drive improved functionality, transaction capability, user adoption and utility, and scaling of bitcoin. LQwD is also securing a substantial position in bitcoin as an operating asset and will use its holdings to establish nodes and payment channels on the Lightning Network.

The Lightning Network is a second-layer protocol, sitting above the bitcoin blockchain, intended to facilitate faster micro-transactions and lower fees on bitcoin transactions, thus allowing mass adoption of bitcoin.

LQwD expects the Lightning Network to eclipse the patchwork of legacy financial networks that are used to move value today. The company’s software will make migration from legacy networks onto the Lightning Network easy and seamless. By onboarding more financial service providers, LQwD intends to grow the value of the Lightning Network.

The company, formerly known as Interlapse Technologies Corp., is harnessing new payment rails built on top of the bitcoin blockchain that are capable of beyond visa-level transaction volumes and backed by bitcoin, the strongest and most well-known cryptocurrency. These new rails, enabled by the Bitcoin Lightning Network, open a vast opportunity and market segment for digital payments and financial services on a global scale. LQwD aims to leverage its position as a public company to enhance trust in its products and services, and leverage its shares as currency for acquisitions, roll-up and growth, as well as to attract and retain top industry talent.


The Lightning Network is a solution to massively scale the use of bitcoin for microtransactions globally, dramatically improving upon fees, as well as providing instant settlement times. The Lightning Network has experienced explosive growth and is expected to continue with the trend as usage increases. Well-known companies, such as Twitter and Square, have expressed their enthusiasm to incorporate Lightning Network into their platforms. The Lightning Network is scalable, global, open, inclusive, permissionless and decentralized. It is made up of nodes connected via payment channels, and enables off-chain, instantaneous and cheap payments at scale.

Upon launch of LQwD’s Lightning Network platform-as-a-service, users will be able to leverage the Lightning Network infrastructure to send payments instantly, securely and inexpensively anywhere in the world. Companies and service providers will be able to conduct Lightning Network transactions in bitcoin by integrating LQwD’s infrastructure with their business or web property. Connected businesses will be able to easily deploy, monitor and manage LQwD’s Lightning Network nodes with no or low-level technical knowledge required. The company fully expects Lightning Network to be a force for global change and to become the monetary exchange network of the future.

The Lightning Network, which is already built, functioning and growing, will advance bitcoin from a store-of-value to a global monetary network through payment utility. The company expects the Lightning Network will propel the growing number of active blockchain wallets to new heights, by increasing bitcoin’s scalability and lowering its fees for users. For coming generations, everything from wealth to experiences will be acquired and transacted virtually, and LQwD sees the Lightning Network as an enabling technology that can bring bitcoin to hundreds of millions of new users across the globe.

Market Outlook

Forbes in August 2021 noted that “private investors are funding companies that are building the infrastructure that will support future growth of crypto and digital assets,” and called public companies building cryptocurrency infrastructure “the hottest part of the crypto market.” While the first wave of investor interest in crypto firms was directed at companies catering to retail investors, investors have now shifted their attention to infrastructure builders, like LQwD FinTech. Forbes did not put an estimated value on the crypto infrastructure market but pointed out that large-scale adoption of cryptocurrencies will only happen when infrastructure is in place to support it. The larger digital payments market, of which crypto payments are a small fraction, is growing at more than 14 percent annually and is forecast to hit $154 billion by 2025.

Management Team

Shone Anstey is co-founder, chairman and CEO at LQwD FinTech. He has 20 years of experience in building complex technologies and has acted as technology lead for an industrial bitcoin mine and bitcoin mining pool. He is a Certified Cryptocurrency Investigator, and an advisor to the British Columbia Securities Commission. He is also co-founder of BIGG Digital Assets (OTCQX: BBKCF) and took that company public in 2017.

Barry MacNeil is CFO at LQwD FinTech. He is a member of the Chartered Professional Accountants of British Columbia and has more than 30 years of management and accounting experience with public companies and in private practice. His previous positions include director of both public companies and nonprofits, as well as Chief Financial Officer and Corporate Controller.

Albert Szmigielski is co-founder and CTO at LQwD FinTech. He was formerly the Head of Research and Chief Blockchain Engineer at Blockchain Intelligence Group and VP Research at CipherTrace. He holds a B.Sc. in Computing Science from Simon Fraser University, and a Master of Science in Digital Currencies and Blockchain Technologies from the University of Nicosia, Cyprus.

LQwD FinTech Corp. (LQWDF), closed Friday’s trading session at $0.115, up 35.2941%, on 78,992,796 volume. The average volume for the last 3 months is 37,044 and the stock's 52-week low/high is $0.1213/$4.00.

Recent News

Asia Broadband Inc. (OTC: AABB)

The QualityStocks Daily Newsletter would like to spotlight Asia Broadband Inc. (AABB).

Pandemic aftershocks have stressed supply chains, which has led to the surge in the price of various commodities, including natural gas and aluminum, with some believing that gold may soon experience a rally as well. Rob McEwen and David Garofalo, former Goldcorp Inc. chiefs, expect investors to realize soon that international inflationary pressures are more intense and less transitory than consumer price indexes and central bankers suggest. Once investors do so, Garofalo expects that the inflation-protection appeal of gold will cause the precious metal’s price to move from its current $1,800 per ounce price to about $3,000 per ounce. In the long term, McEwen expects the precious metal to go $5,000 per ounce. If the price rally that these execs refer to materializes, sector players such as Asia Broadband Inc. (OTC: AABB) are likely to benefit from that price surge.

Asia Broadband Inc. (OTC: AABB) is a resource company focused on the production, supply and sale of precious and base metals, primarily to Asian markets.

The company utilizes its specific geographic expertise, experience and extensive industry contacts to facilitate its innovative distribution process from the production and supply of precious and base metals in Mexico to client sales networks in Asia. This vertically integrated approach to sales transactions differentiates Asia Broadband from its competitors in the mining space.

Development Program in Colima, Mexico

In October 2020, Asia Broadband announced its acquisition of a high potential mineral property in the state of Colima, Mexico. Per the press release, previous geophysics and groundwork have revealed strong indications of significant mineralization in multiple sectors of the property.

The company recently began the construction of exploration and development facilities and infrastructure roads on its Colima property, and plans are underway to extend previous geophysics and groundwork on the property. In January 2021, Asia Broadband announced its allocation of $10 million for the initial development program, with the aim of accelerating operations at the Colima site toward production.

Positioned in a major gold-iron-copper production area, the company’s Colima property is situated approximately 25 kilometers east of the Pena Colorada mine in Minatitlan, Mexico. It is advantageously located, with direct access to main Highway #3, and the property also has an essential natural water supply.

AABB Gold Token

In December 2020, Asia Broadband announced its entry into a definitive development agreement with Core State Holdings Corp., a digital assets and crypto wallet creator, to produce a white label gold-backed cryptocurrency coin. The AABB Gold token is an ERC-20 token being developed on the Ethereum blockchain.

In a February 2021 news release, the company provided a development update on the cryptocurrency token, noting that Core State Holdings Corp. “is continuing to modify the set-up and move through the final stages of testing of the iOS and Android AABB Wallet applications, including the implementation of an application interface to allow users to see the real-time exchange rate of gold that backs the price of the AABB Gold token set at one-tenth of a gram or approximately $5.80 USD.”

Core State Holdings Corp. has also continued to enhance, which the company notes will be the go-to knowledge base for all information concerning the soon-to-be launched AABB Wallet and AABB Gold token.

AABB’s primary goal for the token is to become a worldwide standard of exchange – secured and trusted with gold backing – by expanding circulation and targeting large population and high growth markets globally, including China and East Asia.

Asia Broadband Inc. (AABB), closed Friday’s trading session at $0.0155, up 23.0159%, on 470,912,473 volume. The average volume for the last 3 months is 154.77M and the stock's 52-week low/high is $0.0026/$0.659.

Recent News

FuelPositive Corp. (TSX.V: NHHH) (OTC: NHHHF)

The QualityStocks Daily Newsletter would like to spotlight FuelPositive Corp. (NHHHF).

FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF) has achieved several milestones and made strategic investments that bring it even closer to its ultimate goal of providing sustainable, clean energy to reduce carbon emissions. The company, which is pushing for the change from fossil fuels, has appointed André Mech, who will lend his years of experience to the strategic carbon credit and emissions reduction specialist position, helping FuelPositive sell its carbon credits in the same way Tesla does. With the hydrogen economy being at the core of the company’s agenda, FuelPositive is spearheading the modular and scalable carbon-free ammonia industry. “To date, FuelPositive has managed to achieve three main milestones for the 2021 fiscal year: process determination, primary component vendor selection and procurement, and engineering design,” reads a recent article. “Going forward into 2022, the company plans to put systems in place for demonstration projects with partners and ramp up production capability in the early half of the year and start shipping commercial systems in the last quarter of 2022.” To view the full article, visit

FuelPositive Corp. (TSX.V: NHHH) (OTC: NHHHF) is a growth stage company focused on licensing, partnership and acquisition opportunities building upon various technological achievements. The company is committed to providing commercially viable and sustainable clean energy solutions, including carbon-free ammonia (NH3), for use across a broad spectrum of industries and applications.

FuelPositive is headquartered in Toronto, Canada.

Hydrogen Economy Problems and FuelPositive’s Carbon-Free Technology

The hydrogen economy is currently facing many challenges. Traditional NH3 manufacturing exists on a massive scale, but centralized facilities result in some of the world’s most concentrated CO2 emissions. In total, an estimated 200 million metric tonnes of NH3 are consumed each year, with greater than 80% utilized by the agricultural sector. NH3 is also being positioned as a viable alternative to fossil fuels.

FuelPositive’s flagship carbon-free ammonia technology provides an innovative solution to these environmental concerns. Developed by Dr. Ibrahim Dincer and his team, the company’s platform allows for the in-situ production of NH3 in an entirely sustainable manner, using only water, air and sustainable electricity.

The production of hydrogen is energy intensive, but it is just one variable hindering the growth of the hydrogen economy. Other hurdles include:

  • Storage – The storage of hydrogen by compression or liquification are both cost prohibitive and unsustainable.
  • Distribution – The distribution network for effective hydrogen deployment has yet to be developed, as the extreme high-pressure distribution requirements to transport hydrogen would result in enormous infrastructure costs.
  • End Use – R&D on the transportation-related end use applications for hydrogen is in its infancy, but almost any vehicle on the road today can be easily converted to run on NH3 at a considerably lower cost per mile traveled when compared to traditional fossil fuels.

A key benefit of FuelPositive’s patent-pending, first-of-its-kind carbon-free NH3 technology is its flexibility. The process allows for small, medium or large-scale production of NH3 on location, minimizing or even eliminating the challenges and volatility associated with storage and transportation to end use. As such, with an appropriately sized FuelPositive system and access to renewable energy, the end use applications for the company’s platform are nearly infinite.

Manufacturing Partnership

On May 19, 2021, FuelPositive announced its selection of National Compressed Air Canada Ltd. (“NCA”) to undertake manufacturing of the company’s Phase 2 hydrogen-ammonia synthesizer commercial prototype systems for carbon-free ammonia production.

In a news release detailing the partnership, FuelPositive CEO Ian Clifford noted, “This critical milestone for FuelPositive will confirm the broad application potential for our technology and is the backbone of our Carbon-Free Hydrogen-NH3 offering. Partnering with the knowledgeable and experienced team at NCA on this commercialization project will bring our development-stage program to life.”

Global Ammonia Market Outlook

The global ammonia market was valued at $52.71 billion in 2017 and is forecast to reach $81.42 billion by 2025, growing at a CAGR of 5.59%, according to data from Fior Markets (

The agricultural industry consumes more than 80% of global NH3. Smaller percentages can be attributed to the waste, water treatment, refrigerants, antiseptic, textile, mining and pharmaceutical industries.

One of the most polluting industries on the planet consists of conventional agribusinesses. These polluters are responsible for more greenhouse emissions per year than transportation. This is where FuelPositive’s technology is expected to be extremely beneficial.

Management Team

Ian Clifford is Director, CEO and Founder of FuelPositive Corp. He has over 25 years of experience in the fields of technology and marketing and has successfully led the company to global brand recognition through its unique energy solutions. Since 2006, Mr. Clifford has raised over $50 million in equity financing for FuelPositive. He also co-founded digIT Interactive, a full-service internet marketing company serving Fortune 500 clients, which he sold at the peak of the market in 2000.

Greg Gooch serves as a Director and President of FuelPositive. His multifaceted career in the electronics and finance industries has positioned him as a key advisor and funding partner to start-ups and new technology companies for over 40 years. Mr. Gooch has been involved with FuelPositive since its early days and has remained a significant supporter and consultant to the company over the years. He has a bachelor’s from McGill University and an MBA from the University of Western Ontario.

Dr. Ibrahim Dincer is a scientific advisor to FuelPositive and is recognized as a pioneer and international leader in the area of sustainable energy technologies. Along with his team, Dr. Dincer invented the modular carbon-free ammonia (NH3) production technology that FuelPositive is commercializing. His area of specialty covers various topics including ammonia, hydrogen energy and fuel cells; renewable energy systems; energy storage systems and applications; carbon capturing technologies, and integrated and hybrid energy systems He is currently managing an exemplary team of researchers in this commercialization project.

Marek Warunkiewicz is the company’s Communications & Branding Specialist. He brings more than 40 years of entrepreneurial expertise to the FuelPositive team, having held marketing, branding, advertising, project management and graphic design positions with various companies. Mr. Warunkiewicz has successfully created business-to-business marketing and advertising campaigns for a diverse group of clients ranging from high-tech to agriculture. He co-founded digIT Interactive and ZENN Motor Company alongside Ian Clifford.

Luna Clifford is the Director of Communications for FuelPositive. She has over 10 years of experience as a business owner and advisor, helping build and operate several successful start-up enterprises while managing complex stakeholder relationships. Ms. Clifford excels in strategic planning and team building, and she has completed extensive studies in the fields of communications and health care.

FuelPositive Corp. (NHHHF), closed Friday’s trading session at $0.009, up 4.6512%, on 210,000 volume. The average volume for the last 3 months is 1.243M and the stock's 52-week low/high is $0.03224/$0.326.

Recent News

Hero Technologies Inc. (OTC: HENC)

The QualityStocks Daily Newsletter would like to spotlight Hero Technologies Inc. (OTC: HENC).

Hero Technologies (OTC: HENC) is focused on becoming fully licensed in Michigan as part of its ongoing commitment to position itself as a multistate operator in the cannabis sector. Its BlackBox Systems and Technologies LLC subsidiary fulfilled the requirements for step 1 prequalification approval for a Class C Medicinal Use cannabis license in Michigan and received step 1 prequalification approval for a Class C Adult-Use cannabis license. “With those approvals in hand, Hero Technologies and BlackBox are now beginning the next — and last — step in the process of obtaining licensing approval in Michigan: establishment use or full license approval for a newly constructed medical marijuana facility, which will allow HENC to move forward with its plans for cultivation of cannabis in Michigan,” reads a recent article. “In addition to its Michigan expansion plans, Hero Technologies is undertaking expansion in Colorado through its wholly owned subsidiary Mile High Green LLC… HENC is also planning to expand in Massachusetts through its wholly owned subsidiary MassCannabis LLC. In addition, Hero Technologies owns and operates two hemp websites: under Highly Relaxing LLC and” To view the full article, visit: Marijuana businesses have been unable to access financial services such as deposit accounts, cashless payments and loans since legal sales began in America. This is mostly due to the controversial plant’s classification as a Schedule I controlled drug, and it has had wide-ranging consequences on both cannabis businesses and federal authorities. Players in the cannabis space are forced to transact on a cash-only basis, increasing their chances of robberies and making it difficult to account for and pay taxes. Furthermore, federal authorities, the IRS specifically, don’t often receive taxes that are due, and when they do, it is usually in large amounts of cash. Cannabis banking reform will not only benefit the IRS but will also remove a major bottleneck faced by the entire marijuana industry, including sector players such as Hero Technologies Inc. (OTC: HENC).

Hero Technologies Inc. (OTC: HENC) is a cannabis company with a vertically integrated business model and plan that includes cannabis genetic engineering, farmland for medical and recreational cannabis cultivation, production licenses, distribution licenses, consumer packaging, retail operations and dispensaries that make the organization a multi-state operator (MSO).

The company was founded in 2004 and is headquartered in Dover, Delaware.


The company holds the majority stake in BlackBox Systems and Technologies LLC, an aeroponic cannabis cultivation firm focused on providing optimal conditions to enhance photosynthesis and cultivation. Hero Technologies is planning expansion in cultivation and dispensary operations in Colorado through wholly owned subsidiary Mile High Green LLC, while expansion in Massachusetts is planned through another wholly owned subsidiary, MassCannabis LLC.

Hero Technologies also owns and operates under Highly Relaxing LLC and recently acquired the assets of V Brokers LLC, now operating as Veteran Hemp Co. at

BlackBox Systems and Technologies LLC

BlackBox Systems and Technologies LLC markets a proprietary cannabis aeroponic cultivation system designed for the large-scale production of top-shelf cannabis products. BlackBox offers the optimal conditions to enhance photosynthesis and promote the cultivation of large flowering plants. The system’s dry room, process room and secure storage were designed for precise control through each phase of the cannabis lifecycle. Weekly harvests are achieved using 13 separate BlackBox systems in independent modules.

The system provides a series of key benefits, including:

  • High-pressure nutrient delivery, with no nutrient or PH deficiencies
  • Sterile, 100% nutrient solution
  • Drain to Waste (no reuse of wastewater)
  • Low water usage (1 gallon per plant per day)
  • Constant PH and EC in reservoirs
  • Modular design (1 to 100 pods in any configuration)
  • Innovative proprietary engineering
  • Minimal cleanup
  • Media-less growing, suspended in the air, with no media waste
  • No pesticides

Highly Relaxing LLC

Highly Relaxing LLC is an emerging Henderson, Nevada-based operation dedicated to providing customers with honestly labeled, high-quality hemp-derived CBD products. Its current offerings include a topical CBD cream that provides localized relief from potential discomfort.

Veteran Hemp Co.

Veteran Hemp Co.’s mission is to provide a quality, consistent and delicious product for Americans looking to enjoy the hemp smoking experience. Its product is brought in by only the finest farming operations delivering the best genetics. Veteran Hemp Co. has its own custom harvest plans, drying facilities and all of the logistics that fall between. Veteran Hemp Co. prides itself on being a veteran-approved company.

Market Outlook

The global legal cannabis market is anticipated to reach $84 billion by 2028, expanding at a CAGR of 14.3% from 2021 to 2028. The driving factor for this forecast expansion is the increasingly widespread legalization of cannabis for medical and recreational use. Recreational use accounted for 60.3% of industry revenue in 2020.

North America provided the largest revenue share in the cannabis market, accounting for 91.1% of the global market in 2020. Due to the early legalization of medical and recreational cannabis in the region, the customer pool has increased exponentially (

The global CBD market was valued at $2.8 billion in 2020 and is expected to grow at a CAGR of 21.2% and reach $13.4 billion by 2028. North America is considered the most progressive region for cannabis and its derived products, with the highest number of CBD companies being based on the continent. The B2B (business to business) segment dominates the CBD industry, accounting for the largest revenue share at 59.6% in 2020 (

With its vertically integrated business model and development into a multi-state operator across multiple sectors of the cannabis industry, Hero Technologies is uniquely positioned to capitalize on the fast-growing market and the growing number of opportunities emerging as a result of legalization and increased popularity among consumers.

Management Team

Gina Serkasevich, CPA, CMA, is the Chief Executive Officer, Treasurer and Secretary of the Hero Technologies. She previously worked for Holloman Corporation as its Director of Finance beginning in June 2012 and was appointed Chief Financial Officer of Holloman Energy Corporation in August 2014. She has more than 30 years of domestic and international corporate accounting and finance experience. She served as U.S. Controller for EFLO Energy Inc., a company focused on the acquisition, exploration and development of oil and gas assets in North America. Prior to 2012, Ms. Serkasevich worked in the oil and gas tanker transportation industry as a Regional Financial Manager for AET Inc. Limited (2011-2012), as a Financial Consultant for OSG Ship Management Inc. (2009-2011) and as a Financial Controller/CFO for Stena Bulk LLC (1998-2008). During her 11-year tenure at Stena Bulk LLC, she established the financial, accounting and reporting requirements for its new joint ventures and tanker pools with Sonanagol USA and held the Company Secretary position on both of those companies’ boards of directors.

Dan McCarthy is the company’s Corporate Development Manager. He has spent more than 12 years in the institutional investment community, holding various investment banking and private equity executive roles. Thus far, he has been a part of over $1 billion in transactional value ranging from debt and equity to acquisitions and diversities throughout his career. Mr. McCarthy’s most recent role was Managing Director at Petro Capital, a Dallas-based private equity and investment bank. He began his career working for a private international consulting firm based in Washington, D.C., helping corporations and funds expand into non-G7 countries utilizing World Bank financing. He is also a graduate of the University of Kansas School of Business and completed the Mergers and Acquisitions program at the New York Institute of Finance.

James Rowland is Hero Technologies’ Marketing Advisor and an expert in marketing and e-commerce. He has held many high-level marketing and business-related roles. He is the Founder and current CEO of and the current Business Development Specialist at Mr. Rowland has held multiple high-level positions throughout his career, which have provided him with the experience needed to bring success-backed marketing leadership skills to his current role with the company.

Hero Technologies Inc. (HENC), closed Friday’s trading session at $0.29, even for the day, on 120 volume. The average volume for the last 3 months is 33,436 and the stock's 52-week low/high is $0.0243/$0.3174.

Recent News

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF)

The QualityStocks Daily Newsletter would like to spotlight Red White & Bloom Brands Inc. (OTCQX: RWBYF).

  • RWB appointed Chris Ecken as the new CFO effective October 2021
  • Ecken will lend over 25 years of experience from the alcohol beverage industry, helping RWB to shape sustainable long-term growth
  • RWB also announced Colby De Zen’s appointment to its board of directors
  • He will be integral to RWB’s move to close critical assets in Michigan and expedite expansions in Florida, California, Arizona, Illinois, Massachusetts and Oklahoma
  • RWB also completed Platinum Vape LLC. (“PV”) management transition, with the addition of Shea Alderete, Joaquin Rodriguez and Craig Rosevear to its management
  • RWB plans to bank on growing demand in Michigan and California to scale up production of PV vape carts

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF) has announced the appointment of two new members to its team: Christopher Ecken and Colby De Zen. Experienced financial executive Chris Ecken becomes the company’s new Chief Financial Officer (“CFO”), while strategic investor and entrepreneur Mr. Colby De Zen becomes the company’s newest board member. The move is being made to strengthen the executive team and its board.

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) is a torchbearer blazing a new frontier in American cannabis by adhering to the highest ethical, manufacturing, educational, branding and employment standards available in the industry.

Red White & Bloom is a super state operator, leveraging a sizable footprint to dominate the areas in which it operates. CEO Brad Rogers and other management members have seen the struggles of multi-state operators who have spread themselves too thin, which is why Red White & Bloom is intent on dominating each state it enters before expanding further.

Although targeting individual states in the United States, the company is headquartered in Toronto, Canada. Red White & Bloom was established after privately held MichiCann Medical Inc. merged with publicly traded Tidal Royalty in 2019.


Red White & Bloom has entered strategic brand acquisitions and partnerships aimed at helping the company expand its presence and position as one of the largest players in the United States cannabis market. Red White & Bloom is always diligently searching for brands to acquire that will provide additional value to the company and expand its national footprint.

The company’s current brand portfolio includes:

  • Platinum Premium Cannabis Products (PV): Platinum uses innovative thinking, honesty and responsibility to remain at the forefront of the cannabis industry. PV holds itself and its partners to the highest standards, providing clean and safe CBD and THC products. In the company’s press release dated January 13, 2021, it reported system-wide sales of Platinum-branded products exceeding $2.8 million for the first week of January alone.
  • High Times®: In June 2020, the company acquired the licensing rights and branding of High Times dispensaries and High Times cannabis-based CBD and THC products in Michigan, Illinois and Florida. The company also acquired branding of High Times hemp derived CBD products nationally in the United States carrying the Culture® brand.
  • Mid-American Growers: Mid-American began as a family operation in 1971 in Granville, Illinois. The original 8-acre greenhouse has expanded to a 3.6-million-square-foot, state-of-the-art technology and science facility under glass. Mid-American’s product offerings include its CBD Icy Relief Salve, CBD Icy Relief Roll-on and CBD Gummies.

Retail Focus

Red White & Bloom is working to establish a significant retail presence across multiple jurisdictions. In Michigan, the company is invested in and has the rights to acquire (subject to regulatory approvals) a licensed operator that controls the assets of 18 dispensary locations throughout the state. Red White & Bloom is also pursuing opportunities in Florida aimed at making its proposed retail footprint compelling and attractive to the majority of cannabis consumers within each state.


Red White & Bloom is focused on standardization and quality, with everything guided by a relentless commitment to the highest standards. The company acquired a 3.6-million-square-foot standardized facility dedicated to helping it achieve premium value for the products it intends to cultivate.

As it continues to expand, the company remains committed to the practices that have guided its success in the past, including:

  • A top-down approach to cultivation developed under the guidance of PhDs with expertise in growing principles, SOPs and, most importantly, the science behind it all.
  • Commitment to exceeding the requirement of the states in which it operates. The company cut its teeth under the world’s first national cannabis purity regime – a regime that most new markets use as a benchmark – so quality is in its DNA.
  • Science-driven production methods supported by automated, perpetual, standardized operations that enable craft cannabis-like quality at an industrial scale.


Assuming completion of the currently proposed investments and acquisitions, Red White & Bloom will be among the cannabis market’s largest companies, joining the ranks of a select few multi-state operators dominating the industry. Red White & Bloom currently has assets (closed and in closing stages) in Michigan, Illinois, Florida, California, Oklahoma and Massachusetts.

The company’s strategic acquisition and super state operator model, combined with its commitment to top-quality product and service, position it to become a leading player in the North American cannabis market.

When evaluated beside competitors in the cannabis space, Red White & Bloom boasts an extremely attractive valuation. While large cap cannabis firms serving North American markets averaged enterprise-value-to-EBITDA multiples of 14.9x as of December 2020, Red White & Bloom’s enterprise multiple was just 3.4x, as noted in the company’s latest investor deck.

In 2020, the cannabis market worldwide was valued at $24.6 billion. This amount is expected to expand at a CAGR of 14.3% from 2021 to 2028, resulting in a market size of $84 billion in 2028 ( Of the 2020 valuation, the largest revenue share (91.1%) was attributed to North American consumers (

Management Team

Brad Rogers is the CEO and Executive Chair of Red White & Bloom. He is a visionary for the future of cannabis and CBD products in the United States market, with a proven track record of building successful and profitable businesses in the rapidly expanding and new economic sector. Mr. Rogers was a part of the team that built one of the first commercially scaled production facilities in the world for medicinal cannabis. He also served as President for one of the leading licensed producers in Canada. Both of his ventures were successful, with a combined market cap of $2 billion.

Michael Marchese is the company’s Co-Founder and Marketing Advisor. He has played a crucial role in its development and organization, overseeing capital raises, acquisition strategy and brand identity. Mr. Marchese has a strong reputation and presence in the cannabis industry. He also co-founded and directed the branding of Aleafia Health Inc., which he continues to counsel. Through his branded company, Marchese Design, he has served as a highly trusted counselor to top-level execs, including C-Suite level employees, offering insights into the process of creating, building and maintaining brand identities.

Theo van der Linde is the CFO and Director of Red White & Bloom. He is a Chartered Accountant with 20 years of experience in finance, administration and public accounting. The experience he has acquired spans multiple industries, including mining, oil & gas, financial services, retail and manufacturing. For the last nine years, he has primarily focused his career on the mining industry, working with junior exploration and producing mining companies at various stages of growth in several jurisdictions. Mr. van der Linde is also the current President of Executive Management Solutions Ltd.

Red White & Bloom Brands Inc. (RWBYF), closed Friday’s trading session at $3.46, off by 1.4245%, on 230,738 volume. The average volume for the last 3 months is 956,825 and the stock's 52-week low/high is $0.405/$1.65.

Recent News

The QualityStocks Daily Newsletter would like to spotlight is a next generation platform where consumers can play the lottery online – in browser or via smartphone app. The platform offers users access to official lottery games sanctioned by their individual states and also provides lottery data to more than 400 digital publishers, including Google and Amazon Alexa. was founded in 2015, launching at the LAUNCH festival and soon turning into a leader in the industry. With headquarters in Austin, Texas, the company is dedicated to helping advance the lottery industry into the digital age and works closely with state regulatory bodies to achieve this goal.

The company recently entered into a definitive agreement for a business combination with special purpose acquisition company Trident Acquisitions Corp. (NASDAQ: TDAC) (“Trident”), which will result in becoming a publicly listed company. Once the transaction is complete, the combined company will be trademarked as, with its common stock to remain listed on Nasdaq under ticker symbol ‘LTRY’. Online Platform

The online platform works closely with state regulators, advancing the lottery into the digital age. With the online platform, the company offers enhanced regulatory capabilities by leveraging innovative blockchain technology and capturing the untapped market of digitally native players.

Players go online in a browser or through a mobile application to use the interface. The process includes:

  • Players Choose a Game: Players can play officially state sanctioned multi-state games and other games offered in the states in which they live. Players can also find winning numbers, jackpot totals, draw dates and more for hundreds of other lottery games around the world.
  • Players Pick Numbers: Players can play their lucky numbers or do a quick pick of randomized numbers in as simple as two taps. “Tap, Tap, Ticket!”
  • A Safe and Secure Way to Play: Purchases for up to 50 tickets can be made at one time through the online interface. handles everything after purchase, letting users know when they win.
  • Collect All Winnings: Consumers keep 100% of their winnings. All winnings stay in the balance for future ticket purchases, or a cashout can be requested. Company representatives contact winners who hit big jackpots, instructing them on the redemption process.

A Better Way to Play the Lottery has an innovative e-commerce platform that is using blockchain to maintain an accurate ledger. From 2016 to 2020, grew gross revenue at a CAGR of 363%, and it forecasts gross revenue equal to approximately $71 million in 2021, $279 million in 2022, and $571 million in 2023. is leveraging a successful playbook, with $398 billion in global lottery sales but only 6.7% online penetration. The large market opportunity is expected to shift to online transactions within the next decade.

The platform is currently available in 12 states across the United States, and the company plans to expand to 34 by the end of 2023. Global expansion is also on the horizon, with partnership plans in Turkey and Ukraine.

Key features that make the experience unique include:

  • All the Games Users Love – For consumers who live in applicable LIVE states, Powerball and Mega Millions are available right from the mobile application.
  • Convenience – makes playing the lottery on mobile devices easy. After setting up an account, users can begin playing in moments or set reminders to play when the jackpot is high.
  • Easy Cashouts – Users can cash out winnings straight to a bank account, safely and securely, with no commissions.

The company is also gamifying charitable giving, fundamentally changing how nonprofits engage with donors and raise funds. is a platform designed to offer charitable donation sweepstakes to incentivize donors to take action by offering large cash prizes and once-in-a-lifetime experiences.

Strong Advisory Board Presence is expected to continue to gain support, leaning on the experience of its advisory board and notable investors from the venture capital, gaming and entertainment industries. These include:

  • Jason Robins, CEO of DraftKings Inc. (NASDAQ: DKNG)
  • Ben Narasin, Venture Partner of NEA
  • Peter Diamandis, Chairman of XPRIZE Foundation
  • Matthew Le Merle, Co-Founder and Managing Partner of Fifth Era and Keiretsu Capital
  • Paraag Marathe, President of Enterprises and EVP of Football Operations for the San Francisco 49ers
  • Jamie Gold, The Poker Philanthropist

Management Team

Tony DiMatteo is the Co-Founder and Chief Executive Officer of He is a serial entrepreneur and highly sought-after industry speaker and thought leader. He has been featured in The Wall Street Journal, Forbes, VentureBeat, TechCrunch Inc. and more for his approach to entrepreneurship, the gaming industry and cryptocurrency.

Matt Clemenson is the Co-Founder and Chief Commercial Officer of He is responsible for the company’s strategy. Mr. Clemenson was steeped in corporate and enterprise engineering processes at Hotwire and Expedia before going on to be CEO at LesConcierges, the world’s largest concierge company, which merged into John Paul and sold to Accor Hotels. Clemenson and DiMatteo have been partners for more than 10 years.

Ryan Dickinson is the company’s President and Chief Operating Officer. He has a diverse background in business, technology, product, design and sales, which has aided him in producing many successful outcomes throughout his career. Notably, as Senior Vice President of a SaaS company, Mr. Dickinson produced profitability from a negative $1.4 million division within the first year by reinventing the product offerings, streamlining processes and establishing a go-to-market strategy. Additionally, he produced three record breaking revenue years in a row for AccuWeather, the world’s largest weather provider, by increasing every KPI for all flagship properties by no less than 5%.

Luc Vanhal is the company’s Chief Financial Officer. He has served in C-level executive roles since the 1990s, including a nine-year tenure for The Walt Disney Company (NYSE: DIS) from 1990 to 1999. From 2001 to 2004, he managed the development of the World of Warcraft massively multiplayer game, which, by the end of 2020, still had over five million active subscribers. As the CFO of, Mr. Vanhal leads the company’s global finance organization, with treasury responsibility, accounting, analysis and financial planning.

Recent News


Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF)

The QualityStocks Daily Newsletter would like to spotlight Mydecine Innovations Group Inc. (MYCOF).

Mydecine Innovations (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA), a biotechnology and digital technology company aiming to transform the treatment of mental health and addiction disorders, will be participating in the Wonderland: Miami. Hosted by Microdose, the upcoming event is scheduled for Nov. 8–9, 2021, and will be held in Miami at the Adrienne Arsht Center for the Performing Arts. Wonderland participants can meet with Mydecine management during the two-day premiere gathering. To view the full press release, visit

Mydecine Innovations Group Inc. (NEO: MYCO) (NASDAQ: MYCOF) is a biotechnology and digital technology company aiming to transform the treatment of mental health disorders and addiction. Founded in 2020 on the guiding principle that there is a significant unmet need and lack of innovations in the mental health and therapeutic treatment environments, Mydecine is dedicated to efficiently developing innovative first- and second-generation novel therapeutics to treat PTSD, addiction and other mental health disorders.

Mydecine’s business model combines clinical trials and data outcome, technology and scientific and regulatory expertise with a focus on psychedelic therapy underpinned by novel molecules with differentiated therapeutic potential. By collaborating with some of the world’s foremost authorities connected by best practices, Mydecine aims to responsibly fast-track the development of new medicines across its platforms, ultimately changing the way we treat mental health disorders. The company seeks to bridge the gap between the needs of patients and what the mental health care system currently provides.

Mydecine Innovations Group is headquartered in Denver with international offices in Canada and Europe.

Research and Technology

The invention and development of novel psychedelic and non-psychedelic molecules for medical use is an important part of Mydecine’s research strategy. The company uses molecules found in nature as building blocks to create improved second-generation drugs. This portfolio of new drugs represents major improvements to existing natural products and synthetics, including enhanced safety, efficacy, stability and dosing, as well as reduced side effects.

The goal of creating these improved second-generation compounds is to enable safer, more effective treatments for patients, along with improved management of dosage and drug behavior for clinicians. Mydecine believes the multibillion-dollar market for mental health and addiction disorder medicines will soon be disrupted amid a resurgence of the study into psychedelics and data showing the immense benefits of these forms of medicine.

The company currently has four lead drug candidates which include various enhancements such as improved controllability, delivery mechanisms, safety, stability and shelf-life. The drug candidates are in clinical trials or in pre-trial stage as potential treatments to aid PTSD, substance abuse and smoking cessation.

Mindleap Health is a wholly owned subsidiary of Mydecine. The Mindleap platform is a virtual community that aims to foster the conscious and responsible adoption of psychedelic medicine into inner wellness. Users access the platform through the Mindleap app. Mindleap provides users with inner wellness resources to assist them in their daily mental-health journeys. The platform also seeks to support the conscious and trustworthy adoption of psychedelics into a widely accepted approach to mental health and inner wellness.

Market Outlook

The global smoking cessation market is expected to reach $63.99 billion by 2026, growing at a CAGR of 16.9 percent from 2018 to 2026. The market for psychedelic therapeutics is in its very early stages. Estimates of current market value and forecasts of expected value in future years are all over the map. Market forecasts range from $6.5 billion by 2030 with a CAGR of 15 percent, to more than $69 billion as soon as 2025, at a CAGR of 8.2 percent. What is clear is that interest in psychedelic therapeutic drugs is expanding rapidly.

Management Team

Joshua Bartch is Chief Executive Officer and Chairman of Mydecine Innovations Group. He is an experienced entrepreneur who co-founded and founded Denver-based dispensary Doctors Orders in 2009. He also founded a boutique investment firm that operated throughout the U.S. and Canadian markets. In 2014, Bartch co-founded, the USA’s most significant and sophisticated legal cannabis wholesale platform.

Dr. Rakesh Jetly, OMM, CD, MD, FRCPC, is the Chief Medical Officer of Mydecine. He was formerly Chief of Psychiatry for the Canadian Armed Forces, retiring in 2021 with the rank of colonel after 31 years of service. He began his career as a general duty medical officer and flight surgeon and spent his final 20 years of service as a psychiatrist. He maintains academic appointments at Dalhousie University and The University of Ottawa. He is the inaugural CF Brigadier Jonathan C. Meakins CBE, RCMAC, Chair in Military Mental Health at the Royal Ottawa Hospital.

Robert Roscow is Chief Scientific Officer of Mydecine. As a geneticist, he has spent his academic and professional careers looking for valuable and unique medicinal molecules found in nature. His innovations were applied at Canopy Growth and ebbu, where he ran those companies’ genetics divisions. He has leveraged his expertise to maximize industrial production of cannabinoids in a pharmacological context, resulting in multiple patent filings.

Damon Michaels is Chief Operating Officer of Mydecine. He previously consulted for various hemp businesses through his company, Emerald Baron. Before that, he served as GM for ebbu, the leading multi-platform cannabinoid research and technology firm based in Colorado. He has held leading roles with multiple large brands throughout the cannabis vertical. He also developed a national snowboard brand.

Mydecine Innovations Group Inc. (MYCOF), closed Friday’s trading session at $0.3151, off by 5.6587%, on 205,883 volume. The average volume for the last 3 months is 823,713 and the stock's 52-week low/high is $0.1257/$2.20.

Recent News

Green Hygienics Holdings Inc. (OTCQB: GRYN)

The QualityStocks Daily Newsletter would like to spotlight Green Hygienics Holdings Inc. (OTCQB: GRYN).

Green Hygienics Holdings (OTCQB: GRYN), an enterprise focused on the high-standard cultivation and processing of industrial hemp, is one company expected to gain from the newly signed Assembly Bill 45 (“AB45”), which is set to benefit companies that grow and produce industrial hemp. AB45 allows for hemp-derived cannabinoids, extracts and derivatives in food and dietary supplements. “The company grows its hemp in a controlled environment at its farm in California, which, with 824 acres and 392,000 square feet of greenhouse space, is the largest USDA Certified Organic Hemp for CBD farm in North America,” reads a recent article. “The company will soon manufacture pharmaceutical-grade bioactive cannabinoids and other active ingredients that can be used for multiple applications in various sectors such as the pharmaceutical, nutraceutical and skin care industries. Green Hygienics is registered with the FDA and was granted USDA Organic Certification in 2020. Products available from the company are currently found in the U.S. and will be in the international markets soon.” To view the full article, visit:

Green Hygienics Holdings Inc. (OTCQB: GRYN) is a California-based innovative technology-driven enterprise focused on the high standard cultivation and processing of industrial hemp and manufacturing of pharmaceutical-grade bioactive cannabinoids.

The company aims to be a leader in compliance and capabilities in the hemp and cannabinoid supply marketplace. By leveraging state of the art technologies, the company intends to open up a whole new world of novel cannabinoids and targeted bio-delivery technologies never before explored, solving the issues of stability, pharmacokinetics, biological tissue penetration and bioavailability.

Dedicated to creating the hemp industry’s safest and finest quality products, the company will be uniquely positioned to deliver product efficacy and supply chain solutions to consumers, as well as to leverage these within its own products and brand portfolio.

USDA Organic Certification and FDA Registration

On August 26, 2020, Green Hygienics registered with the U.S. Food and Drug Administration pursuant to the Federal Food Drug and Cosmetic Act, as amended by the Bioterrorism Act of 2002. This registration strengthens the company’s core mission to provide product efficacy to the pharmaceutical industry and consumers alike.

On September 30, 2020, Green Hygienics was granted USDA Organic Certification (7 CFR Part 205) for the cultivation and post-harvest processing of industrial hemp by the California Certified Organic Farmers for its Sol Valley Ranch property. This certification further enables the company to supply certified organic hemp products to national and international markets.

Market Opportunity

Green Hygienics is focused on finding, acquiring and developing strategically positioned businesses, as well as the best innovations within the hemp industry – a fast-progressing market with remarkable opportunities for growth. The industrial hemp market is expected to reach $5.33 billion in 2020 and is projected to rise to $15.26 billion by 2027, achieving a CAGR of 15.8%, per Grand View Research.

Capital Structure

GRYN has less than 42 million shares outstanding, fully diluted. The company has just 7.2 million common shares in float and boasts a balance sheet with no toxic debt or overhang.

Key Management

Dr. Levan Darjania serves as the company’s Chief Science Officer. Darjania has over 26 years of experience in biotechnology and pharmaceutical drug development. His research and development experience has led him to develop many in-house and collaborative R&D programs over the course of his career.

Kyle MacKinnon serves as GRYN’s Chief Operating Officer. He has extensive knowledge in cannabis processing and was previously the Business Development Manager of Advanced Extraction Systems Inc., a leader in CO2 Supercritical Fluid Extraction. MacKinnon brings over 20 years of sales and management experience to the company.

Ronald Loudoun is the President, CEO, Secretary and Director of Green Hygienics. He received an undergraduate business degree from the British Columbia Institute of Technology. Before joining Green Hygienics, he was the founder and a director of renewable energy firm Archer CleanTech Inc.

Jerry Halamuda is the Senior Vice President of Business Development of the company’s Agriculture Division. He has an extensive career working in the agriculture and horticulture industry. Halamuda has founded, managed and operated multiple successful companies, including Color Spot Nurseries.

John Gildea is GRYN’s Senior Vice President of Corporate Development. He has over 20 years of experience working within the private and public markets. His expertise includes negotiating and structuring private and public financing and mergers. During the course of his work, Gildea has established trusted relationships with a network of equity and capital partners.


Green Hygienics Holdings Inc. (OTCQB: GRYN), closed Friday’s trading session at $0.3148, off by 3.9072%, on 81,258 volume. The average volume for the last 3 months is 14,639 and the stock's 52-week low/high is $0.45755/$2.45.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

closed Wednesday's trading